Mehrdad Arjomandi1,2, John R Balmes2,3, Mark W Frampton4,5, Philip Bromberg6,7, David Q Rich4,5,8, Paul Stark9, Neil E Alexis10,7, Maria Costantini11, Danielle Hollenbeck-Pringle9, Nicholas Dagincourt9, Milan J Hazucha6,7. 1. 1 San Francisco Veterans Affairs Medical Center, San Francisco, California. 2. 2 Department of Medicine, University of California at San Francisco, San Francisco, California. 3. 3 Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, California. 4. 4 Department of Medicine. 5. 5 Department of Environmental Medicine, and. 6. 6 Department of Medicine and. 7. 7 Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, North Carolina. 8. 8 Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York. 9. 9 New England Research Institute, Watertown, Massachusetts; and. 10. 10 Department of Pediatrics, School of Medicine, and. 11. 11 Health Effects Institute, Boston, Massachusetts.
Abstract
RATIONALE: Acute respiratory effects of low-level ozone exposure are not well defined in older adults. OBJECTIVES: MOSES (The Multicenter Ozone Study in Older Subjects), although primarily focused on acute cardiovascular effects, provided an opportunity to assess respiratory responses to low concentrations of ozone in older healthy adults. METHODS: We performed a randomized crossover, controlled exposure study of 87 healthy adults (59.9 ±4.5 yr old; 60% female) to 0, 70, and 120 ppb ozone for 3 hours with intermittent exercise. Outcome measures included spirometry, sputum markers of airway inflammation, and plasma club cell protein-16 (CC16), a marker of airway epithelial injury. The effects of ozone exposure on these outcomes were evaluated with mixed-effect linear models. A P value less than 0.01 was chosen a priori to define statistical significance. MEASUREMENTS AND MAIN RESULTS: The mean (95% confidence interval) FEV1 and FVC increased from preexposure values by 2.7% (2.0-3.4) and 2.1% (1.3-2.9), respectively, 15 minutes after exposure to filtered air (0 ppb). Exposure to ozone reduced these increases in a concentration-dependent manner. After 120-ppb exposure, FEV1 and FVC decreased by 1.7% (1.1-2.3) and 0.8% (0.3-1.3), respectively. A similar concentration-dependent pattern was still discernible 22 hours after exposure. At 4 hours after exposure, plasma CC16 increased from preexposure levels in an ozone concentration-dependent manner. Sputum neutrophils obtained 22 hours after exposure showed a marginally significant increase in a concentration-dependent manner (P = 0.012), but proinflammatory cytokines (IL-6, IL-8, and tumor necrosis factor-α) were not significantly affected. CONCLUSIONS: Exposure to ozone at near ambient levels induced lung function effects, airway injury, and airway inflammation in older healthy adults. Clinical trial registered with www.clinicaltrials.gov (NCT01487005).
RCT Entities:
RATIONALE: Acute respiratory effects of low-level ozone exposure are not well defined in older adults. OBJECTIVES: MOSES (The Multicenter Ozone Study in Older Subjects), although primarily focused on acute cardiovascular effects, provided an opportunity to assess respiratory responses to low concentrations of ozone in older healthy adults. METHODS: We performed a randomized crossover, controlled exposure study of 87 healthy adults (59.9 ± 4.5 yr old; 60% female) to 0, 70, and 120 ppb ozone for 3 hours with intermittent exercise. Outcome measures included spirometry, sputum markers of airway inflammation, and plasma club cell protein-16 (CC16), a marker of airway epithelial injury. The effects of ozone exposure on these outcomes were evaluated with mixed-effect linear models. A P value less than 0.01 was chosen a priori to define statistical significance. MEASUREMENTS AND MAIN RESULTS: The mean (95% confidence interval) FEV1 and FVC increased from preexposure values by 2.7% (2.0-3.4) and 2.1% (1.3-2.9), respectively, 15 minutes after exposure to filtered air (0 ppb). Exposure to ozone reduced these increases in a concentration-dependent manner. After 120-ppb exposure, FEV1 and FVC decreased by 1.7% (1.1-2.3) and 0.8% (0.3-1.3), respectively. A similar concentration-dependent pattern was still discernible 22 hours after exposure. At 4 hours after exposure, plasma CC16 increased from preexposure levels in an ozone concentration-dependent manner. Sputum neutrophils obtained 22 hours after exposure showed a marginally significant increase in a concentration-dependent manner (P = 0.012), but proinflammatory cytokines (IL-6, IL-8, and tumor necrosis factor-α) were not significantly affected. CONCLUSIONS: Exposure to ozone at near ambient levels induced lung function effects, airway injury, and airway inflammation in older healthy adults. Clinical trial registered with www.clinicaltrials.gov (NCT01487005).
Authors: Daniel Schuch; Edmilson Dias de Freitas; Sergio Ibarra Espinosa; Leila Droprinchinski Martins; Vanessa Silveira Barreto Carvalho; Bruna Ferreira Ramin; Jayne Sousa Silva; Jorge Alberto Martins; Maria de Fatima Andrade Journal: Environ Sci Pollut Res Int Date: 2019-09-04 Impact factor: 4.223
Authors: Jacklyn Nguyen; Cassandra E Deering-Rice; Brittnie S Armstrong; Christopher Massa; Christopher A Reilly; Alessandro Venosa Journal: Toxicol Sci Date: 2022-08-25 Impact factor: 4.109
Authors: Hao Chen; Haiyan Tong; Wan Shen; Tracey S Montilla; Martin W Case; Martha A Almond; Heather B Wells; Neil E Alexis; David B Peden; Ana G Rappold; David Diaz-Sanchez; Robert B Devlin; Philip A Bromberg; James M Samet Journal: Environ Int Date: 2022-07-13 Impact factor: 13.352
Authors: Jelena Mustra Rakic; Siyang Zeng; Linnea Rohdin-Bibby; Erin L Van Blarigan; Xingjian Liu; Shuren Ma; John P Kane; Rita F Redberg; Gerard M Turino; Eveline Oestreicher Stock; Mehrdad Arjomandi Journal: Chronic Obstr Pulm Dis Date: 2022-07-29
Authors: Chris C Lim; Richard B Hayes; Jiyoung Ahn; Yongzhao Shao; Debra T Silverman; Rena R Jones; Cynthia Garcia; Michelle L Bell; George D Thurston Journal: Am J Respir Crit Care Med Date: 2019-10-15 Impact factor: 21.405
Authors: Michelle L Hernandez; Sally Ivins; Kelly Chason; Allison J Burbank; Meghan E Rebuli; Aaron Kobernick; Stephen A Schworer; Haibo Zhou; Neil E Alexis; David B Peden Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 21.405
Authors: Maria A Zoran; Roxana S Savastru; Dan M Savastru; Marina N Tautan; Laurentiu A Baschir; Daniel V Tenciu Journal: Environ Res Date: 2021-08-06 Impact factor: 8.431